10-48171068-C-T
Position:
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 0P and 2B. BP4_Moderate
The NM_001018071.4(FRMPD2):c.3364G>A(p.Glu1122Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.0 ( 0 hom., cov: 23)
Exomes 𝑓: 0.0000097 ( 0 hom. )
Failed GnomAD Quality Control
Consequence
FRMPD2
NM_001018071.4 missense
NM_001018071.4 missense
Scores
2
3
14
Clinical Significance
Conservation
PhyloP100: 3.55
Genes affected
FRMPD2 (HGNC:28572): (FERM and PDZ domain containing 2) This gene encodes a peripheral membrane protein and is located in a region of chromosome 10q that contains a segmental duplication. This copy of the gene is full-length and is in the telomeric duplicated region. Two other more centromerically proximal copies of the gene are partial and may represent pseudogenes. This full-length gene appears to function in the establishment and maintenance of cell polarization. The protein is recruited to cell-cell junctions in an E-cadherin-dependent manner, and is selectively localized at the basolateral membrane in polarized epithelial cells. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -2 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.2009885).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
FRMPD2 | NM_001018071.4 | c.3364G>A | p.Glu1122Lys | missense_variant | 26/29 | ENST00000374201.8 | |
FRMPD2 | NM_001318191.1 | c.3289G>A | p.Glu1097Lys | missense_variant | 24/27 | ||
FRMPD2 | NM_001042512.3 | c.397G>A | p.Glu133Lys | missense_variant | 3/6 | ||
FRMPD2 | XM_017015744.2 | c.220G>A | p.Glu74Lys | missense_variant | 3/6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
FRMPD2 | ENST00000374201.8 | c.3364G>A | p.Glu1122Lys | missense_variant | 26/29 | 1 | NM_001018071.4 | P2 |
Frequencies
GnomAD3 genomes AF: 0.00 AC: 0AN: 146698Hom.: 0 Cov.: 23 FAILED QC
GnomAD3 genomes
AF:
AC:
0
AN:
146698
Hom.:
Cov.:
23
FAILED QC
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00000975 AC: 7AN: 718048Hom.: 0 Cov.: 9 AF XY: 0.00000262 AC XY: 1AN XY: 381770
GnomAD4 exome
AF:
AC:
7
AN:
718048
Hom.:
Cov.:
9
AF XY:
AC XY:
1
AN XY:
381770
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Data not reliable, filtered out with message: AC0;AS_VQSR AF: 0.00 AC: 0AN: 146698Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 71038
GnomAD4 genome
Data not reliable, filtered out with message: AC0;AS_VQSR
AF:
AC:
0
AN:
146698
Hom.:
Cov.:
23
AF XY:
AC XY:
0
AN XY:
71038
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 10, 2021 | The c.3364G>A (p.E1122K) alteration is located in exon 26 (coding exon 26) of the FRMPD2 gene. This alteration results from a G to A substitution at nucleotide position 3364, causing the glutamic acid (E) at amino acid position 1122 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
T;T;.
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
D
LIST_S2
Uncertain
D;D;D
M_CAP
Benign
T
MetaRNN
Benign
T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
.;N;.
MutationTaster
Benign
N;N;N;N
PrimateAI
Pathogenic
T
PROVEAN
Uncertain
.;D;D
REVEL
Benign
Sift
Benign
.;D;D
Sift4G
Pathogenic
.;D;D
Polyphen
0.28, 0.20
.;B;B
Vest4
0.31, 0.31
MutPred
Gain of ubiquitination at E1122 (P = 0.0155);Gain of ubiquitination at E1122 (P = 0.0155);.;
MVP
0.13
MPC
2.4
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at